McKesson Ventures came onboard for the health data provider Evidation's series D round, helping it hike its overall funding to $106m.

US-based health data provider Evidation Health completed a $45m series D round on Wednesday that included McKesson Ventures, the strategic investment arm of healthcare product distributor McKesson.

The round was led by venture capital firm B Capital Group and also featured Section 32, Revelation Partners, Rethink Impact and SV Health Investors. It increased the company’s funding to $106m since it was founded in 2012.

Evidation has created a software platform that passively collects data on everyday behaviour from sources like…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.